Neurones Total Assets from 2010 to 2026
| NRO Stock | EUR 36.40 2.75 7.02% |
Total Assets | First Reported 2000-06-30 | Previous Quarter 725.7 M | Current Value 717.7 M | Quarterly Volatility 176.9 M |
Check Neurones financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Neurones' main balance sheet or income statement drivers, such as Interest Expense of 2 M, Total Revenue of 978.6 M or Operating Income of 94.1 M, as well as many indicators such as Price To Sales Ratio of 0.82, Dividend Yield of 0.0258 or PTB Ratio of 1.57. Neurones financial statements analysis is a perfect complement when working with Neurones Valuation or Volatility modules.
Neurones | Total Assets |
Analyzing Neurones's Total Assets over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Total Assets has evolved provides context for assessing Neurones's current valuation and future prospects.
Latest Neurones' Total Assets Growth Pattern
Below is the plot of the Total Assets of Neurones over the last few years. Total assets refers to the total amount of Neurones assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Neurones books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. Neurones' Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Neurones' overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 725.69 M | 10 Years Trend |
|
Total Assets |
| Timeline |
Neurones Total Assets Regression Statistics
| Arithmetic Mean | 474,887,267 | |
| Geometric Mean | 410,060,706 | |
| Coefficient Of Variation | 47.29 | |
| Mean Deviation | 183,022,282 | |
| Median | 449,056,000 | |
| Standard Deviation | 224,596,208 | |
| Sample Variance | 50443.5T | |
| Range | 813.9M | |
| R-Value | 0.99 | |
| Mean Square Error | 1267.1T | |
| R-Squared | 0.98 | |
| Slope | 43,949,876 | |
| Total Sum of Squares | 807095.3T |
Neurones Total Assets History
About Neurones Financial Statements
Neurones stakeholders use historical fundamental indicators, such as Neurones' Total Assets, to determine how well the company is positioned to perform in the future. Although Neurones investors may analyze each financial statement separately, they are all interrelated. For example, changes in Neurones' assets and liabilities are reflected in the revenues and expenses on Neurones' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Neurones. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Total Assets | 834.5 M | 876.3 M | |
| Intangibles To Total Assets | 0.09 | 0.14 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Neurones Stock
Neurones financial ratios help investors to determine whether Neurones Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Neurones with respect to the benefits of owning Neurones security.